The Oregon Board of Pharmacy permanently adopted the following rules at the June 2023 Board Meeting:
- Divisions 006/041/043/045/080/139/141 related to Standards Adopted by Reference *Effective 6/13/2023
- Divisions 019/020 related to Pharmacist Prescriptive Authority *Effective 6/13/2023
- Continuation of Therapy including Emergency Refills of Insulin v. 6/2023
- Travel Medications v. 6/2023
- HIV Post-exposure Prophylaxis (PEP) v. 6/2023
- HIV Pre-exposure Prophylaxis (PrEP) v. 6/2023
- Contraception v. 6/2023
- Divisions 019/041/043/045/080/139/141/143 related to Annual Self-Inspection Form Completion Date *Effective 8/1/2023
Also in Oregon, the House passed the following bills this week:
- HB 2725 (A-Engrossed), legislation prohibiting PBMs from retroactively denying or reducing payment on a claim after adjudication unless the pharmacy and the PBM agree that payment was incorrect due to a clerical error and requiring PBMs, if denying or reducing reimbursement on a claim, to provide notice to the pharmacy of the specific claim that is denied or reduced and an explanation for the denial or reduction.
- HB 3013 (B-Engrossed), legislation requiring PBMs to be licensed by the Department of Consumer & Business Services, amending the definition of “pharmacy benefit manager”, establishing a rate floor, permitting pharmacies to file a complaint with the Department of Consumer & Business Services, imposing new requirements to coverage of 340B drugs and various other provisions.
For more information, contact NACDS’ Sandra Guckian at 703-774-4801.